Laddar...

A highly sensitive LC-MS/MS method to determine novel Bruton's tyrosine kinase inhibitor spebrutinib: application to metabolic stability evaluation

Spebrutinib (SBT) is a Bruton's tyrosine kinase inhibitor. SBT is currently in phase II and phase I clinical trials for the management of rheumatoid arthritis and chronic lymphocytic leukaemia, respectively. We developed and validated a liquid chromatography tandem mass spectrometry analytical...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:R Soc Open Sci
Huvudupphovsmän: Abdelhameed, Ali S., Attwa, Mohamed W., Al-Shaklia, Nasser S., Kadi, Adnan A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: The Royal Society 2019
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6599791/
https://ncbi.nlm.nih.gov/pubmed/31312501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rsos.190434
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!